Breaking News Instant updates and real-time market news.

KURA

Kura Oncology

$15.55

-0.45 (-2.81%)

16:12
05/07/19
05/07
16:12
05/07/19
16:12

Kura says current cash, investments sufficient to fund operations into 2021

  • 07

    May

  • 07

    May

KURA Kura Oncology
$15.55

-0.45 (-2.81%)

12/03/18
PIPR
12/03/18
NO CHANGE
Target $25
PIPR
Overweight
Kura Oncology remains 'favorite smallcap oncology name', says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren kept his Overweight rating and $25 price target on Kura Oncology following the company's update on the development of tipifarnib in highly refractory PTCL patients where a significant association between CXCL12 expression and clinical benefit was observed. The analyst notes that the data were "particularly impressive given the patients' refractory states and importantly, one patient was even able to receive a potentially curative transplant". Van Buren further contends that Kura Oncology is positioned for $500M or more in long-term sales for tipifarnib in HRAS-driven cancers, adding that its "shares are significantly undervalued based on that opportunity alone".
01/07/19
PIPR
01/07/19
NO CHANGE
Target $235
PIPR
Overweight
Piper Jaffray views price paid for Loxo by Eli Lilly as fair
Piper Jaffray analyst Tyler Van Buren views the price of $235 per share paid by Eli Lilly (LLY) for Loxo Oncology (LOXO) as fair. The analyst says the price is near the $250-plus he previously thought was achievable in an acquisition scenario for Loxo. Other names in the precision medicine/oncology space that could be up today as a result of the buyout are Agios Pharmaceuticals (AGIO), ArQule (ARQL), Array BioPharma (ARRY), Blueprint Medicines (BPMC), Kura Oncology (KURA), Mirati Therapeutics (MRTX) and others, Van Buren tells investors in a research note. He raised his price target for Loxo Oncology to $235 from $200 and keeps an Overweight rating on the shares.
01/18/19
PIPR
01/18/19
NO CHANGE
Target $25
PIPR
Overweight
Kura Oncology shares remain 'significantly undervalued,' says Piper Jaffray
Kura Oncology today provided evidence that tipifarnib could be active in patients with no abdominal pain and/or nodal/liver met disease, both of which are associated with high CXCL12 expression, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. The analyst estimates tipifarnib's opportunity in the HRAS-driven head and neck squamous cell carcinomas opportunity alone is worth $500M-plus in peak sales. However, with the recent data in CXCL12-driven peripheral T-cell lymphomas presented and now potentially pancreatic cancer, these estimates "could be pushed significantly higher over time," Van Buren adds. He continues to believe Kura Oncology shares are "significantly undervalued" and keeps an Overweight rating on the name with a $25 price target.
04/03/19
PIPR
04/03/19
NO CHANGE
PIPR
Overweight
Piper says Kura's potential patient population for tipifarnib keeps growing
After Kura Oncology presented additional data on tipifarnib, a farnesyltransferase inhibitor/HRAS inhibitor that downregulates expression of CXCL12, Piper Jaffray analyst Tyler Van Buren said the number of potential indications for the drug "continues to multiply" as initial clinical data suggest diffuse large B-cell lymphoma and cutaneous T-cell lymphoma patients could benefit from treatment in addition to the already identified cancer indications. The "broad mechanism of tipifarnib is becoming clear" and the potential patient population keeps growing, "well beyond what investors are currently appreciating," according to Van Buren. He keeps an Overweight rating on Kura shares.

TODAY'S FREE FLY STORIES

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

17:42
05/23/19
05/23
17:42
05/23/19
17:42
Hot Stocks
HP Inc. says PC growth across industry was subdued this quarter »

Continue to gain momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

RST

Rosetta Stone

$24.93

1.135 (4.77%)

17:38
05/23/19
05/23
17:38
05/23/19
17:38
Hot Stocks
Rosetta Stone officer Sonia Galindo sells over $107K in company shares »

Rosetta Stone officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

CCF

Chase Corporation

$100.72

0.32 (0.32%)

17:32
05/23/19
05/23
17:32
05/23/19
17:32
Hot Stocks
Chase Corporation chairman sells 2K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNR

RenaissanceRe

$170.85

-0.34 (-0.20%)

17:24
05/23/19
05/23
17:24
05/23/19
17:24
Syndicate
Breaking Syndicate news story on RenaissanceRe »

RenaissanceRe files $750M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

17:21
05/23/19
05/23
17:21
05/23/19
17:21
Syndicate
Breaking Syndicate news story on RTI Surgical »

RTI Surgical files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 17

    Jun

DXC

DXC Technology

$52.00

-2.5 (-4.59%)

17:21
05/23/19
05/23
17:21
05/23/19
17:21
Earnings
DXC Technology sees FY20 adjusted EPS $7.75-$8.50, consensus $9.21 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

17:19
05/23/19
05/23
17:19
05/23/19
17:19
Syndicate
Breaking Syndicate news story on RTI Surgical »

RTI Surgical files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 17

    Jun

RTN

Raytheon

$179.79

-1.01 (-0.56%)

17:15
05/23/19
05/23
17:15
05/23/19
17:15
Hot Stocks
Raytheon awarded $355.49M Navy contract for AGM-88B missiles »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

DVAX

Dynavax

$6.36

(0.00%)

17:15
05/23/19
05/23
17:15
05/23/19
17:15
Hot Stocks
Breaking Hot Stocks news story on Dynavax 

Dynavax trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

COST

Costco

$248.62

-0.93 (-0.37%)

17:11
05/23/19
05/23
17:11
05/23/19
17:11
Recommendations
Costco analyst commentary  »

Baird recommends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

MYND

MYnd Analytics

$1.16

0.14 (13.73%)

17:06
05/23/19
05/23
17:06
05/23/19
17:06
Hot Stocks
MYnd Analytics director John Pappajohn purchases 200K shares of company stock »

MYnd Analytics director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBOE

Cboe Global Markets

$106.40

-1.45 (-1.34%)

17:05
05/23/19
05/23
17:05
05/23/19
17:05
Hot Stocks
Cboe Global Markets EVP Harkins sells 4.3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGNX

MacroGenics

$18.64

0.18 (0.98%)

16:56
05/23/19
05/23
16:56
05/23/19
16:56
Hot Stocks
Integrated Core Strategies reports 5.7% passive stake in MacroGenics »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

IMRN

Immuron

$4.90

(0.00%)

16:49
05/23/19
05/23
16:49
05/23/19
16:49
Syndicate
Immuron announces offering to sell ADSs »

Immuron Limited announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROLL

RBC Bearings

$140.52

1.84 (1.33%)

16:47
05/23/19
05/23
16:47
05/23/19
16:47
Hot Stocks
RBC Bearings announces $100M share repurchase program »

RBC Bearings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 05

    Jun

DVAX

Dynavax

$6.36

(0.00%)

16:47
05/23/19
05/23
16:47
05/23/19
16:47
Hot Stocks
Dynavax to restructure to focus on vaccine business »

Dynavax Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

CNC

Centene

$55.45

-1.33 (-2.34%)

, WCG

WellCare

$274.46

-3.54 (-1.27%)

16:45
05/23/19
05/23
16:45
05/23/19
16:45
Hot Stocks
Centene, WellCare announce special meeting date, transaction to close by 1H20 »

Centene (CNC) and…

CNC

Centene

$55.45

-1.33 (-2.34%)

WCG

WellCare

$274.46

-3.54 (-1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 23

    Jul

DVAX

Dynavax

$6.36

(0.00%)

16:42
05/23/19
05/23
16:42
05/23/19
16:42
Hot Stocks
Breaking Hot Stocks news story on Dynavax »

Dynavax trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

DNKEY

Danske Bank

$0.00

(0.00%)

16:39
05/23/19
05/23
16:39
05/23/19
16:39
Downgrade
Danske Bank rating change at Goldman Sachs »

Danske Bank downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WD

Walker & Dunlop

$51.59

-0.92 (-1.75%)

16:39
05/23/19
05/23
16:39
05/23/19
16:39
Hot Stocks
Walker & Dunlop President Howard Smith sells $4M in company shares »

Walker & Dunlop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TD

Toronto-Dominion

$56.01

1.05 (1.91%)

16:36
05/23/19
05/23
16:36
05/23/19
16:36
Downgrade
Toronto-Dominion rating change at National Bank »

Toronto-Dominion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

16:36
05/23/19
05/23
16:36
05/23/19
16:36
General news
Money Supply M2 Weekly Change data reported »

Week of 5/13 Money Supply…

GWGH

GWG Holdings

$15.25

0.05 (0.33%)

16:36
05/23/19
05/23
16:36
05/23/19
16:36
Hot Stocks
GWG Holdings receives noncompliance notification from Nasdaq »

GWG Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSA

National Storage

$29.80

-0.195 (-0.65%)

16:35
05/23/19
05/23
16:35
05/23/19
16:35
Hot Stocks
National Storage 'elevates' its CEO Arlen Nordhagen to Executive Chairman »

National Storage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 04

    Jun

16:34
05/23/19
05/23
16:34
05/23/19
16:34
General news
Fed Balance Sheet Level data reported »

Week of 5/22 Fed Balance…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.